<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03563495</url>
  </required_header>
  <id_info>
    <org_study_id>MSCs in alveolar cleft repair</org_study_id>
    <nct_id>NCT03563495</nct_id>
  </id_info>
  <brief_title>Tissue Engineered Constructs for Alveolar Cleft Repair</brief_title>
  <official_title>Clinical, Volumetric and Densitometric Evaluation of Tissue Engineered (TE) Constructs for Secondary Alveolar Cleft Reconstruction (Short Term Randomized Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Description of the research question&#xD;
&#xD;
      In children undergoing unilateral alveolar cleft reconstruction, would stem cells carried on&#xD;
      collagen scaffold provide bone of a good quality and quantity if compared to autogenous bone&#xD;
      grafting?&#xD;
&#xD;
      Objective of the study:&#xD;
&#xD;
      â€¢ Research hypothesis&#xD;
&#xD;
      The tissue engineered constructs will provide sufficient bone of a good quality and quantity&#xD;
      if compared to autogenous bone graft in children undergoing unilateral alveolar cleft&#xD;
      reconstruction.&#xD;
&#xD;
        -  The objectives&#xD;
&#xD;
      The primary objective:&#xD;
&#xD;
      Assessment of bone volume (quantity) which will be provided by tissue engineered constructs&#xD;
      compared to that provided by autogenous bone for maxillary alveolar cleft reconstruction.&#xD;
&#xD;
      The secondary objective:&#xD;
&#xD;
      Assessment of bone density (quality) which will be provided by tissue engineered constructs&#xD;
      compared to that provided by autogenous bone for maxillary alveolar cleft reconstruction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of changes in the bone volume at the grafted alveolar cleft site from the immediate postoperative to 6 months</measure>
    <time_frame>Immediate postoperative and after 6 months</time_frame>
    <description>Measuring the bone volume on CT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of changes in the bone density at the grafted alveolar cleft site from the immediate postoperative to 6 months</measure>
    <time_frame>Immediate postoperative and after 6 months</time_frame>
    <description>Measuring the bone density on CT scan</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Cleft Lip and Palate</condition>
  <arm_group>
    <arm_group_label>tissue engineered group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>autogenous bone marrow derived and cultured stem cells loaded on collagen matrix was implanted in the alveolar cleft in the study group (1st arm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>autogenous bone graft group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>autogenous cortico-cancellous bone graft harvested from the anterior iliac crest was implanted in the alveolar cleft of the control group (2nd arm)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>tissue engineered group</intervention_name>
    <description>cultured and bone marrow derived autologous mesenchymal stem cells, loaded on collagen matrix (Osteovit)</description>
    <arm_group_label>tissue engineered group</arm_group_label>
    <other_name>BM-MSCs on collagen matrix (Osteovit)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autogenous bone graft group</intervention_name>
    <arm_group_label>autogenous bone graft group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children with maxillary unilateral alveolar clefts requiring reconstruction&#xD;
&#xD;
          -  Children free from any systemic disease that may affect normal healing of bone&#xD;
&#xD;
          -  Children in an age range (8-14) year.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Bilateral alveolar clefts.&#xD;
&#xD;
          -  Cleft lip or palate not including the alveolus.&#xD;
&#xD;
          -  Immunocompromized patients.&#xD;
&#xD;
          -  Children who undergone previous bone grafting procedure for the alveolar cleft&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 26, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2018</study_first_posted>
  <last_update_submitted>June 19, 2018</last_update_submitted>
  <last_update_submitted_qc>June 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Walaa Kadry</investigator_full_name>
    <investigator_title>principal investigator at Oral &amp; Maxillofacial Surgery department, Faculty of Dentistry, Cairo University</investigator_title>
  </responsible_party>
  <keyword>tissue engineering.</keyword>
  <keyword>stem cells.</keyword>
  <keyword>autogenous grafts.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cleft Lip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

